Porsche AG (P911-P) Report Interpretation

Overview

Goldman Sachs revises down Porsche’s near-term earnings outlook for new restructuring charges and a changed model ramp, while retaining its Buy rating. Its thesis rests on accelerated cost reduction, better high-end 911 mix and a product-led recovery that it expects to become clearer in FY28.

Core views

Goldman Sachs lowers FY27E to reflect approximately €300m of new restructuring-provision expense associated with Porsche’s second personnel package. It also changes delivery assumptions: the 718 internal-combustion-engine return is now expected only from 2029, and eMacan volumes are lowered as an ICE Macan ramp is expected in FY28. Higher eCayenne sales as that model ramps further into FY27 partly offset those changes. The result is lower near-term earnings expectations, with FY26E/FY27E/FY28E EPS cut by 14.3%/12.1%/4.6% to €1.99/€2.16/€3.12, respectively. FY27E revenue is reduced 1.6% to €35.105bn, adjusted EBITDA 6.5% to €6.864bn, and EBIT 12.4% to €2.658bn. The report nonetheless views the second personnel and restructuring agreement as central to its Buy thesis. The additional 5,000 reduction brings planned cumulative headcount cuts to 8,900, roughly 21% of FY25 headcount of 42,000—a proportion Goldman Sachs describes as well above that at other OEMs. Management’s guidance that the second package alone should generate a net restructuring benefit by FY28 means savings from the earlier 3,900-person package, which runs through 2029, could arrive earlier than guided. Goldman Sachs therefore expects SG&A to fall to 11.6% of revenue in FY27 from 12.9% in FY25, helping offset volume pressure. Price and mix are the other near-term offset. Goldman Sachs expects significant average-selling-price increases from a maturing 911 variant mix and sees possible special/top-end 911 products as helping to close the 2027 volume gap. It expects price/mix and SG&A initiatives to support the near term, followed by volume recovery over 2026E–2030E. The 7 October capital-markets day is important because Porsche is expected to provide details on the product-portfolio revamp, medium- and long-term financial targets, and the timing of restructuring benefits; Goldman Sachs also sees it as a plausible setting for a special 911 reveal. Despite the estimate reductions, Goldman Sachs remains ahead of Visible Alpha consensus on several later-year measures. Its FY28E revenue estimate of €37.651bn is 1.4% above consensus, EBIT of €3.907bn is 15.8% above, EBIT margin of 10.4% is 1.3 percentage points above, and EPS of €3.12 is 15.7% above. The report values Porsche using an unchanged 20x forward P/E multiple applied to blended FY27/28 EPS of €2.64, producing a 12-month target price of €53, reduced from €57. It remains Buy.

Analysis framework

Goldman Sachs updates delivery and model-ramp assumptions, incorporates restructuring charges and expected cost savings, then assesses whether price/mix, SG&A improvement and later product recovery can offset the near-term volume gap. It compares its forecasts with consensus and applies a forward P/E multiple to blended FY27/28 EPS to set the target price.

Methodology notes

• Valuation methodsP/E and PEG Valuation

  Forward P/E valuation using blended FY27/28 EPS

  Goldman Sachs applies an unchanged 20x price-to-earnings multiple to its €2.64 blended FY27/28 EPS estimate to derive the €53 12-month target price.

• Industry AnalysisVolume-price decomposition

  Volume, price/mix and cost-offset analysis

  The report separates the effects of lower deliveries and changed model ramps from higher 911 mix, possible special-model pricing and SG&A savings to explain the earnings path.

Asset mapping & comparison

Structured mapping from thesis to named assets (strengths, weaknesses, peers, risks).

• Porsche AG (P911-P.DE)

  Primary covered company; expected to benefit from personnel-cost reductions, improving 911 mix and product recovery after near-term delivery pressure.

  Strengths

  Cumulative 8.9k headcount reduction, potential earlier savings from the first package, expected 911 ASP improvement and eCayenne ramp.

  Weaknesses

  FY27 restructuring charges, delayed 718 ICE return and lower expected eMacan volumes.

  Comparison

  Goldman Sachs states planned headcount reduction as a percentage of FY25 headcount is higher than at other OEMs; its FY28E profit estimates exceed Visible Alpha consensus.

  Risks

  Product delays, competitive pricing pressure, BEV margin weakness, China deterioration and raw-material disruption.

Key data

• New restructuring provisionsc.€300mFY27E expense associated with the second personnel package.
• Cumulative headcount reduction8.9k / c.21%Includes an incremental 5k reduction; compared with FY25 headcount of 42k.
• FY27 SG&A as % of revenue11.6%Goldman Sachs estimate versus 12.9% in FY25.
• FY26E/FY27E/FY28E EPS revisions-14.3% / -12.1% / -4.6%Revised estimates are €1.99/€2.16/€3.12.
• FY28E EBIT versus consensus€3.907bn / +15.8%Goldman Sachs estimate versus Visible Alpha consensus.
• Target price€5312-month target, reduced from €57; based on 20x blended FY27/28 EPS of €2.64.

Impact & implications

The report says restructuring charges and delayed product timing weigh on FY27, but faster cost phasing, higher-value 911 mix and the product pipeline could support a material recovery by FY28. Confirmation of those drivers at the October capital-markets day is central to the thesis.

Risks

• Further regulatory, supplier or development delays to new product launches could extend the volume gap and postpone delivery and margin recovery.
• More intense competition from European performance peers and Chinese EV entrants could weaken pricing power and the assumed ASP gains.
• Faster electrification requirements or weaker consumer BEV adoption could create BEV and ICE inventory mismatches and margin-dilutive electric-vehicle discounting.
• Higher battery costs, unfavorable platform economics or pricing pressure could leave BEV gross margins below expectations and make 911 mix insufficient to support group margins.
• A sharper China downturn, including tax changes, domestic premium-OEM competition or macro weakness, could push deliveries below Goldman Sachs’ base case.
• Geopolitical tensions, export restrictions or sourcing concentration could disrupt raw-material supply, delay production and increase inputs costs.

What to watch

• The 7 October CMD for details on the portfolio revamp, medium- and long-term targets, and restructuring timing.
• Whether Porsche unveils a top-end or special 911 derivative.
• The pace of cost savings from the first and second personnel packages.
• eCayenne ramp-up, eMacan volumes, ICE Macan timing and the delayed 718 ICE return.
• Delivery recovery, 911 price/mix progression and BEV gross margins.
• China deliveries and raw-material supply conditions.